Lineage Cell Therapeutics logo
Lineage Cell Therapeutics LCTX
$ 0.83 -2.45%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Lineage Cell Therapeutics Total Shareholders Equity 2011-2024 | LCTX

Annual Total Shareholders Equity Lineage Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
63.4 M 73.3 M 92.2 M 96.2 M 113 M 93.8 M 163 M 118 M 26.9 M 36.5 M 14.8 M 9.58 M 28.6 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
163 M 9.58 M 71.5 M

Quarterly Total Shareholders Equity Lineage Cell Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
68.3 M 72.4 M 63.4 M 68.1 M 71.3 M 69 M 73.3 M 77.6 M 81.5 M 85.2 M 92.2 M 120 M 124 M 117 M 96.2 M 96.2 M 96.2 M 96.2 M 113 M 113 M 113 M 113 M 92.2 M 93.8 M 93.8 M 93.8 M 163 M 163 M 163 M 163 M 118 M 118 M 118 M 118 M 25.8 M 26.9 M 26.9 M 26.9 M 36.5 M 36.5 M 36.5 M 36.5 M 14.8 M 14.8 M 14.8 M 14.8 M 9.58 M 9.58 M 9.58 M 9.58 M 28.6 M 28.6 M 28.6 M 28.6 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
163 M 9.58 M 73.7 M